• share
• favorite_border

Barbara A. Masser, MD, Medical Director at BIDMC urgent care centers in Chelsea and Chestnut Hill, offers advice to help you make the right decision when your care can't wait.

• share
• favorite_border

A clinical trial conducted by a multi-disciplinary team from Beth Israel Deaconess Medical Center has identified four novel prototypes of 3D-printed swabs that can be used for COVID-19 testing.

• share
• favorite_border

Physician-scientists at Beth Israel Deaconess Medical Center are now enrolling patients in a clinical trial to evaluate a potential treatment of patients with COVID-19. Part of a multi-site investigation, the trial is evaluating the safety and efficacy of sarilumab, a biologic medication already approved for adults with moderately to severely active rheumatoid arthritis, for the treatment of COVID-19.

• share
• favorite_border

A team of physician-scientists at Beth Israel Deaconess Medical Center are now enrolling patients in a clinical trial to evaluate a common anti-clotting drug for the treatment of COVID-19-positive patients with ARDS. The newly launched trial follows a special report the team published in the Journal of Trauma and Acute Care Surgery that suggested the use of a drug called tPA could reduce deaths among patients with ARDS as a complication of COVID-19.

• share
• favorite_border

As the numbers of patients with confirmed and suspected COVID-19 in the United States continue to rise exponentially, physician-researchers at Beth Israel Deaconess Medical Center (BIDMC), part of Beth Israel Lahey Health, launched a collaborative and open-source effort to address the shortage of swabs that is hampering the nation’s ability to test for and track the spread of the virus. The team’s mission is to catalyze the development and clinical validation of novel designs for swabs for COVID-19 testing that can be manufactured quickly and in large numbers.

• share
• favorite_border

Physician-scientists at Beth Israel Deaconess Medical Center (BIDMC) are now enrolling patients in two clinical trials testing treatment options for COVID-19, the illness caused by the novel coronavirus. Two trials, led by infectious disease specialist Kathryn Stephenson, MD, MPH, will test the antiviral drug remdesivir for safety and efficacy against the respiratory infection that has sickened more than 300,000 and killed more than 15,000 around the world to date.

• share
• favorite_border

BIDMC geriatrician Medha Munshi, MD, breaks down the difference between a geriatrician and a PCP.

• share
• favorite_border

In a new study published today in JAMA, a team of researchers at Beth Israel Deaconess Medical Center (BIDMC) evaluated how health outcomes for low-income older adults who are dually enrolled in both Medicare and Medicaid have changed since the early 2000s.

• share
• favorite_border

BIDMC clinician-researchers provide new evidence about the optimal way to treat patients who carry BRCA mutations who have been diagnosed with breast cancer.

• share
• favorite_border

Rich Schwartzstein, MD, Director of the Carl J. Shapiro Institute for Education and Research at BIDMC, available for interview to discuss his perspective on the MCAT and its use in medical school admissions.

• share
• favorite_border

A monthly roundup of research briefs showcasing recent scientific advances led by Beth Israel Deaconess Medical Center faculty.

• share
• favorite_border

• share
• favorite_border

In a new study, a team of BIDMC researchers evaluate how hospitals awarded for high quality cardiovascular care by the AHA/ACC performed under federal value-based programs.

• share
• favorite_border

February 11 is International Day of Women and Girls in Science, designated by the United Nations Educational, Scientific and Cultural Organization (UNESCO) and UN-Women to promote the critical role women and girls play in science and technology communities. BIDMC has a long history of women researchers in medicine and science. Below is a brief list of only a few of our distinguished women leaders.

• share
• favorite_border

Welcome to the Heart Health Month Special Edition of Beth Israel Deaconess Medical Center’s (BIDMC) Research & Health News Digest. February is Heart Health Month. This special edition includes consumer-friendly news and research briefs specifically tailored to Heart Health Month:

• share
• favorite_border

Jeremy Robbins, MD, a cardiologist at BIDMC, discusses how altering the intensity of your workout or trying a new activity may benefit your cardiovascular and mental health.

• share
• favorite_border

Loryn Feinberg, MD, Director of Women's Cardiovascular Health at BIDMC, discusses how a highly specialized treatment approach is important for women with underlying cardiovascular issues who want to become pregnant as well as for women who develop cardiac problems during pregnancy.

• share
• favorite_border

Patricia Tung, MD, a cardiologist at BIDMC, outlines the key differences between a panic attack and a heart attack.

• share
• favorite_border

A monthly roundup of research briefs showcasing recent scientific advances led by Beth Israel Deaconess Medical Center faculty.

• share
• favorite_border

Researchers at Beth Israel Deaconess Medical Center (BIDMC) have found that orthostatic hypotension was not associated with higher risk of cardiovascular events, falls, or fainting among participants in The Systolic Blood Pressure Intervention Trial. In a study published in the journal Hypertension, the scientists showed that hypertension treatment had no impact on the link between OH and cardiovascular outcomes or other adverse events.